Biología y Biomedicina >
Instituto de Investigaciones Biomédicas de Barcelona (IIBB) >
(IIBB) Artículos >
Closed Access item Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study
Planas, Anna M.
|Keywords:||Uric acid, MMP-9, Oxidative stress, Thrombolysis, Acute stroke|
|Citation:||Journal of Neurology 256(4): 651-656 (2009)|
|Abstract:||Oxidative stress as well as expression and activity of matrix metalloproteinase 9 (MMP-9) are rapidly enhanced after cerebral ischemia. The magnitude of these effects is related to stroke outcome. In human stroke, the extent of oxidative stress correlates well with increased MMP-9 expression. The aim of this study was to evaluate whether treatment with the antioxidant molecule uric acid (UA) decreased the levels of MMP-9 in stroke patients treated with rtPA. The patients were part of a pilot, double-blind, randomized, vehiclecontrolled study of patients with acute stroke treated with rtPA (< 3 h) and randomized to receive an intravenous infusion of UA (n = 16) or vehicle (n = 8). Total matrix metalloproteinase (tMMP)-9 and active (aMMP-9) levels were measured in serum at baseline (< 3 h), at the end of study treatment infusion (< 5.5 h), and at 48 hours. Total MMP-9 and aMMP-9 increased very early after stroke onset in patients allocated vehicle after rtPA therapy. Lower increments of aMMP-9 were associated with better outcome at 3 months. UA treatment was associated with reduced levels of aMMP-9 at T1 (p < 0.02) in multivariate models adjusted for age, NIHSS score, and baseline aMMP-9 levels. The decline of aMMP-9 attained after UA administration supports further clinical assessment of UA therapy in patients with acute stroke.|
|Description:||The final publication is
available at www.springerlink.com|
|Publisher version (URL):||http://dx.doi.org/10.1007/s00415-009-0153-6|
|E-ISSNmetadata.dc.identifier.doi = DOI:||1432-1459|
|Appears in Collections:||(IIBB) Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.